Arlene Ignaccio Blattman, MD
Obstetrics & Gynecology · New York, NYNPI 1811096902
Payments from drug & device makers
Across 104 payments — averaging $28.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$610
- Astellas Pharma US Inc$602
- Mayne Pharma Commercial LLC$428
- AbbVie$291
- Sumitomo Pharma America, Inc.$208
- Coopersurgical, Inc.$130
- plus $703 from 16 others
What the payments were for
- Food & beverage$2,58287%
- Education$38913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 9 | $610 |
| Astellas Pharma US Inc | 14 | $602 |
| Mayne Pharma Commercial LLC | 23 | $428 |
| AbbVie | 12 | $291 |
| Sumitomo Pharma America, Inc. | 10 | $208 |
| Coopersurgical, Inc. | 6 | $130 |
| Millicent US Inc | 2 | $109 |
| Exact Sciences | 5 | $104 |
| Bayer | 4 | $76 |
| Medtronic | 1 | $60 |
| Merck | 3 | $57 |
| Organon | 3 | $52 |
| Organogenesis Inc. | 1 | $39 |
| Agile Therapeutics, Inc. | 2 | $28 |
| Aspira Women's Health Inc | 2 | $27 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Pfizer | 1 | $25 |
| Shield Therapeutics Inc | 1 | $24 |
| Medicem Inc. | 1 | $21 |
| Smith+Nephew | 1 | $19 |
| Myovant Sciences Inc. | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,971 in reported general payments places this provider in the 85th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 15 | $4,173 |
| Estradiol | 43 | $1,980 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 38 | $578 |
| Clobetasol Propionate | 14 | $224 |
| Medroxyprogesterone Acetate | 11 | $211 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New York
- Jin Hee KimNew York$1M
- Carolyn WesthoffNew York$935K
- Mary PolanNew York$862K
- Steven GoldsteinNew York$557K
- Veronica LernerNew York$368K
- Rachana GavaraNew York$290K
- Taraneh ShirazianNew York$287K
- Lisa EngNew York$237K
- Monica DragomanNew York$230K
- Rachel MaschNew York$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.